| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 16, 2005
Accepted on May 8, 2006
From the Clinical Pharmacology Unit (Y., C.M.M., K.M.O., P.H., A.A., S.W., K.M.-P., M.J.A., I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge; the Department of Cardiology (B.M., J.R.C.), University of Wales College of Medicine, Cardiff; and Trinity College (J.B.), Cambridge, UK.
* To whom correspondence should be addressed. E-mail: my105{at}medschl.cam.ac.uk.
Background--Arterial stiffness is an important determinant of cardiovascular risk. Elastin is the main elastic component of arterial wall and can be degraded by a number of enzymes including serine proteases and matrix metalloproteinases (MMPs). Serum MMP-9 levels correlate with arterial stiffness and predict cardiovascular risk. Polymorphisms in the MMP-9 gene are also associated with large artery function in subjects with coronary artery disease. Therefore, we investigated the influence of known MMP-9 (-1562C>T, R279Q) polymorphisms on arterial stiffness in a large cohort of healthy individuals (n=865).
Methods and Results--Aortic pulse wave velocity (PWV) and augmentation index were assessed. Supine blood pressure, biochemical makers, MMP-9 levels, and serum elastase activity (SEA) were also determined. Genomic DNA was extracted and genotyping performed. Aortic PWV, serum MMP-9, and SEA were higher in carriers of the rare alleles for the -1562C>T and R279Q polymorphisms. These polymorphisms were also associated with aortic PWV after correction for other confounding factors. Stepwise regression models with known or likely determinants of arterial stiffness revealed that
60% of the variability in aortic PWV was attributable to age, mean arterial pressure, and genetic variants (P<0.001).
Conclusions--We have demonstrated for the first time that aortic stiffness and elastase activity are influenced by MMP-9 gene polymorphisms. This suggests that the genetic variation in this protein may be involved in the process of large artery stiffening.
This article has been cited by other articles:
![]() |
A. M. Wood and R. A. Stockley Editorial: Unifying the genetics, co-morbidities and management of COPD Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 113 - 117. [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |